Table 4. Cyst lesion numbers and reductions achieved in experiment II.
Groups | CLN | CLNR | CLRR (%) | |
Range | Mean | |||
1 (PBS) | 47–74 | 56.4 | 0 | 0 |
2 (PBS+adj.) | 29–50 | 41.0 | 15.4 | 27.3 |
3 (TRX+adj.) | 11–58 | 31.6 | 24.8 | 44.0 |
4 (rEm-TSP3+adj.) | 4–19 | 10.2 | 46.2 | 81.9 |
5 (PBS) | 46–78 | 54.2 | 0 | 0 |
6 (PBS+CpG) | 26–39 | 34.0 | 20.2 | 37.3 |
7 (TRX+CpG) | 16–47 | 33.8 | 20.4 | 37.7 |
8 (rEm-TSP3) | 29–62 | 42.2 | 12.0 | 22.1 |
9 (rEm-TSP3+CpG) | 9–29 | 21.0 | 33.2 | 61.3 |
adj. = CFA/IFA adjuvant;
CLN = Cyst lesions number;
CLNR = Cyst lesion number reduction;
CLRR = Cyst lesion reduction rate.